Medicare Advantage and Prescription Drug Program Audit and Compliance Quality Assurance Contractor (Part C+D Internal Controls) subcontract with Bland & Associates under contract with Centers for Medicare and Medicaid Services. NCCG provided subject matter expertise to support CMS’ Program Compliance Oversight and Monitoring activities by ensuring that strong program oversight controls remain in place and are adhered to. CMS’ oversight strategy identifies program vulnerabilities and ensure sponsors’ strict adherence to regulatory requirements. The strategy focuses the Agency’s oversight efforts on auditing all Part C and D Medicare Advantage Organizations (MAO), PACE providers, and program attributes that the program business owners identify as representing the utmost harm to beneficiaries and CMS. The audits were performed according to the CMS 2008 Audit Strategy Paper with the MAOs selected and audited in a consistent manner and according to the appropriate 2008 Audit Process paper (2008-AP) and 2008 RO Audit Workload List spreadsheet (2008 RO-AWL). The Audit Populations include all Medicare Advantage Only (MA), Medicare Advantage Prescription Drug Plans (MA-PD), Prescription Drug Plans (PDP), Regional Preferred Provider Plans (RPPO), and Program of All Inclusive Care of the Elderly (PACE).